These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21960080

  • 21. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 22. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G, Spanu A, Solinas P, Babudieri S, Calia GM, Lovigu C, Mannazzu M, Nuvoli S, Piras B, Bagella P, Mura MS, Madeddu G.
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [Abstract] [Full Text] [Related]

  • 23. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ.
    Clin Infect Dis; 2003 Jun; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [Abstract] [Full Text] [Related]

  • 27. Bone mineral density in rural Thai adults living in Khon Kaen province.
    Pongchaiyakul C, Rojroongwasinkul N, Chotmongkol R, Kosulwat V, Charoenkiatkul S, Rajatanavin R.
    J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
    [Abstract] [Full Text] [Related]

  • 28. Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.
    Rey D, Treger M, Sibilia J, Priester M, Bernard-Henry C, Cheneau C, Javier RM.
    Infect Dis (Lond); 2015 Feb; 47(2):88-95. PubMed ID: 25426996
    [Abstract] [Full Text] [Related]

  • 29. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Feb; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Feb; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
    Marcén R, Caballero C, Uriol O, Fernández A, Villafruela JJ, Pascual J, Martins J, Rodriguez N, Burgos FJ, Ortuño J.
    Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
    [Abstract] [Full Text] [Related]

  • 33. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
    Chițu-Tișu CE, Barbu EC, Lazăr M, Bojincă M, Tudor AM, Hristea A, Abagiu AO, Ion DA, Bădărău AI.
    Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Factors influencing bone mineral density in ARV-naive patients at Sanglah Hospital, Bali.
    Masyeni S, Utama S, Somia A, Widiana R, Merati TP.
    Acta Med Indones; 2013 Jul; 45(3):175-9. PubMed ID: 24045386
    [Abstract] [Full Text] [Related]

  • 36. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A, Miller J, Eisman JA, Cooper DA.
    AIDS; 2001 Apr 13; 15(6):703-9. PubMed ID: 11371684
    [Abstract] [Full Text] [Related]

  • 37. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.
    Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, di Gregorio S, Puig J, Gómez G, Clotet B, Negredo E, Osteoporosis Study Group.
    AIDS; 2010 Nov 27; 24(18):2827-33. PubMed ID: 21045635
    [Abstract] [Full Text] [Related]

  • 38. Bone disease in the setting of HIV infection: update and review of the literature.
    Castronuovo D, Cacopardo B, Pinzone MR, Di Rosa M, Martellotta F, Schioppa O, Moreno S, Nunnari G.
    Eur Rev Med Pharmacol Sci; 2013 Sep 27; 17(18):2413-9. PubMed ID: 24089217
    [Abstract] [Full Text] [Related]

  • 39. HIV infection--a risk factor for osteoporosis.
    Thomas J, Doherty SM.
    J Acquir Immune Defic Syndr; 2003 Jul 01; 33(3):281-91. PubMed ID: 12843738
    [Abstract] [Full Text] [Related]

  • 40. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
    Escota GV, Mondy K, Bush T, Conley L, Brooks JT, Önen N, Patel P, Kojic EM, Henry K, Hammer J, Wood KC, Lichtenstein KA, Overton ET.
    AIDS Res Hum Retroviruses; 2016 Jan 01; 32(1):59-67. PubMed ID: 26366785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.